AGL (NM_000643) Human Mass Spec Standard
Specifications
| Product Data | |
| Tag | C-Myc/DDK |
|---|---|
| Species | Human |
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | RC215018 |
| Predicted MW | 174.6 kDa |
| Protein Sequence | |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Labeling Method | Labeled with U- 13C6, 15N4-L-Arginine and U- 13C6, 15N2-L-Lysine |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
| Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_000634 |
| RefSeq Size | 7165 |
| RefSeq ORF | 4596 |
| Synonyms | GDE |
| Locus ID | 178 |
| UniProt ID | P35573 |
| Cytogenetics | 1p21.2 |
| Summary | This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. provided by RefSeq, Jul 2008 |
| Protein Families | Druggable Genome |
| Protein Pathways | Metabolic pathways, Starch and sucrose metabolism |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "AGL" proteins (13)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| PH310005 | AGL MS Standard C13 and N15-labeled recombinant protein (NP_000633) | 10 ug |
$3,360.00
|
|
| PH315495 | AGL MS Standard C13 and N15-labeled recombinant protein (NP_000019) | 10 ug |
$3,360.00
|
|
| LC424591 | Lyophilized AGL HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC424592 | Lyophilized AGL HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC424593 | Lyophilized AGL HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC424972 | Lyophilized AGL HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY424591 | Transient overexpression lysate of amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 1 (as WB positive control) | 100 ug |
$436.00
|
|
| LY424592 | Transient overexpression lysate of amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 3 (as WB positive control) | 100 ug |
$665.00
|
|
| LY424593 | Transient overexpression lysate of amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 2 (as WB positive control) | 100 ug |
$665.00
|
|
| LY424972 | Transient overexpression lysate of amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 4 (as WB positive control) | 100 ug |
$436.00
|
|
| TP310005 | Recombinant protein of human amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 1, 20 µg | 20 ug |
$867.00
|
|
| TP315018 | Recombinant protein of human amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 3, 20 µg | 20 ug |
$867.00
|
|
| TP315495 | Recombinant protein of human amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), transcript variant 4, 20 µg | 20 ug |
$867.00
|
|
Citations
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.